Status:
COMPLETED
The Efficacy of MDI Treatment With an Optimization Algorithm Adjusting Basal-Bolus Parameters in Children and Adolescents With Type 1 Diabetes at a Diabetes Camp
Lead Sponsor:
McGill University
Conditions:
Diabete Mellitus
Diabetes Mellitus, Type 1
Eligibility:
All Genders
8-21 years
Phase:
NA
Brief Summary
Our lab at McGill University has developed an optimization algorithm for T1D MDI patients that estimates optimal basal-bolus parameters (basal injections and insulin-to-carbohydrate ratios) using gluc...
Detailed Description
The objective of this project is to compare our basal-bolus optimization algorithm with physician adjusted basal-bolus parameters using a randomized parallel clinical trial in children and adolescents...
Eligibility Criteria
Inclusion
- Males and females between 8 and 18 years old.
- Clinical diagnosis of type 1 diabetes for at least 12 months. The diagnosis of type 1 diabetes is based on the investigator's judgment; C peptide level and antibody determinations are not needed.
- Undergoing multiple daily injection therapy.
- HbA1c ≤ 11%.
Exclusion
- Serious medical illness likely to interfere with study participation or with the ability to complete the trial by the judgment of the investigator.
- Failure to comply with the study protocol or with team's recommendations.
- Injection of isophane insulin (NPH) or any intermediate-acting insulin
- More than one injection of slow-acting insulin per day.
Key Trial Info
Start Date :
July 2 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 10 2018
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT03764280
Start Date
July 2 2018
End Date
August 10 2018
Last Update
August 15 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Camp Carowanis
Sainte-Agathe-des-Monts, Quebec, Canada, J8C 2Z7